Completed
Phase II Study of Cabazitaxel in Refractory Metastatic Gastric or Gastroesophageal Adenocarcinoma
NCT01757171
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Distal Esophageal Adenocarcinoma, +8 more
- Locations
-
- UCSF Comprehensive Cancer Center San Francisco, California, United States
- Yale University New Haven, Connecticut, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Karmanos Cancer Institute Detroit, Michigan, United States